Publications
Publications
Show Results For
- All HBS Web
(935)
- Faculty Publications (482)
- January 1992
- Teaching Note
Advanced Medical Technology Corporation TN
By: Thomas R. Piper
Teaching Note for (9-287-028). View Details
Keywords: Pharmaceutical Industry
- September 1991 (Revised August 1994)
- Background Note
Note on Pharmaceutical Industry Regulation
Traces the evolution of U.S. regulatory policy towards the pharmaceutical industry over the course of the twentieth century. A major theme is the steady shift away from a policy of 'let the buyer beware' to the creation of a complex and time-consuming review process,... View Details
- September 1991 (Revised February 1993)
- Case
Burroughs Wellcome and AZT (A)
Burroughs Wellcome Co., developer of AZT, the first drug approved by the U.S. Food and Drug Administration for the treatment of Acquired Immune Deficiency Syndrome (AIDS), finds itself under siege in September 1989 by AIDS activists and various segments of the U.S.... View Details
- October 1990 (Revised April 1991)
- Case
RU 486 (A)
Describes the factors faced by Roussel UCLAF, a French drug company, in deciding whether and how to market a controversial new drug, RU 486, which is often called "the French abortion pill." Roussel's decision involved its relations with the French government, its... View Details
- September 1990 (Revised March 1991)
- Supplement
RU 486 (B)
Describes how Roussel UCLAF resolved the dilemma. Intended for use as an in-class handout. View Details
- September 1990 (Revised January 1992)
- Case
Eli Lilly and Co. (A): Globalization
Examines the changes taking place in Eli Lilly in response to the globalization of the pharmaceuticals industry. Identifies the steps taken by management, problems currently faced, and challenges for the future. Allows examination of the process of implementing a... View Details
- August 1990 (Revised January 1992)
- Case
Eli Lilly and Co. (B): Europe
Examines the challenges facing the company in light of the changing economic, regulatory, and competitive environment in the European pharmaceutical industry. Examines the steps taken by the company adapting to this changing situation as part of a total globalization... View Details
- August 1990 (Revised March 1991)
- Case
Eli Lilly and Co. (C): Japan
Describes the process of establishing an independent operation in Japan in the mid-1980s as a result of a decision to make a major investment in the market. Describes the challenges in setting up such an operation and focuses on the role of the country manager in... View Details
- June 1990
- Teaching Note
International Pharmaceuticals Inc. (Abridged), Teaching Note
By: James E. Austin and Tomas Otto Kohn
Keywords: Pharmaceutical Industry
- April 1990
- Case
International Pharmaceuticals Inc. (Abridged)
By: James E. Austin
Keywords: Pharmaceutical Industry
- April 1990 (Revised November 1992)
- Case
Population Services International: The Social Marketing Project in Bangladesh (Abridged)
By: James E. Austin
Population Services International (PSI) was a not-for-profit agency founded to disseminate family planning information and to market birth control products, primarily in less developed countries seeking to curb their population explosions. In 1976, PSI concluded an... View Details
- January 1990 (Revised January 1993)
- Teaching Note
International Pharmaceuticals Inc., Teaching Note
By: W. Carl Kester
Keywords: Pharmaceutical Industry
- August 1989 (Revised October 2005)
- Case
James Burke: A Career in American Business (B)
By: Richard S. Tedlow and Wendy Smith
Covers the history of Tylenol from the autumn of 1982 through the second tampering incident in February 1986. Also deals with other developments in the history of Johnson & Johnson, especially the acquisition and divestiture of Technicare. View Details
- July 1989 (Revised December 1990)
- Case
CIBA-GEIGY Pharmaceuticals: Pharma International
By: John A. Quelch
Examines the decision by Pharma International on whether to launch an antimalarial product in Nigeria and, if so, how that should be implemented. Involves commercial, ethical, and policy considerations. Rich in situation assessment data, the case refers to criticism of... View Details
- April 1989 (Revised January 1994)
- Case
Novo Industri
By: Michael E. Porter and Michael J. Enright
Describes the structure of the insulin industry, a treatment for diabetes and Novo's strategy and competitive position in early 1982. The industry is undergoing significant change and Novo must decide how to defend and build its international position. Designed as an... View Details
- April 1989 (Revised May 1993)
- Case
Novel Combination of Two Drugs (A)
- April 1989
- Supplement
Novel Combination of Two Drugs (B)
- April 1989
- Supplement